Jayantha Liyanage

895 total citations
9 papers, 316 citations indexed

About

Jayantha Liyanage is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Jayantha Liyanage has authored 9 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Infectious Diseases and 3 papers in Health. Recurrent topics in Jayantha Liyanage's work include Virology and Viral Diseases (3 papers), Vaccine Coverage and Hesitancy (3 papers) and Viral Infections and Immunology Research (2 papers). Jayantha Liyanage is often cited by papers focused on Virology and Viral Diseases (3 papers), Vaccine Coverage and Hesitancy (3 papers) and Viral Infections and Immunology Research (2 papers). Jayantha Liyanage collaborates with scholars based in United States, India and Switzerland. Jayantha Liyanage's co-authors include Susan L. Hills, James D. Heffelfinger, Anthony A. Marfin, Kirsten Vannice, Narongsak Chaiyabutr, Batmunkh Nyambat, Sunil Bahl, Darika Kingnate, Visith Sitprija and Henry Wilde and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Vaccine.

In The Last Decade

Jayantha Liyanage

9 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jayantha Liyanage United States 8 177 173 116 99 43 9 316
James Matthias United States 12 134 0.8× 118 0.7× 146 1.3× 36 0.4× 57 1.3× 34 450
Jason Martin United States 11 217 1.2× 89 0.5× 178 1.5× 24 0.2× 15 0.3× 20 348
Joanne Hiebert Canada 13 168 0.9× 84 0.5× 364 3.1× 49 0.5× 18 0.4× 39 468
Joseph P. Shott United States 10 123 0.7× 139 0.8× 56 0.5× 72 0.7× 53 1.2× 16 302
Maria Theresa Alera United States 12 499 2.8× 585 3.4× 87 0.8× 72 0.7× 23 0.5× 17 694
Chule Thisyakorn Thailand 12 261 1.5× 366 2.1× 53 0.5× 30 0.3× 31 0.7× 37 514
Tammy Sylvester United States 11 143 0.8× 133 0.8× 58 0.5× 14 0.1× 40 0.9× 18 279
Omala Wimalaratne Sri Lanka 12 134 0.8× 93 0.5× 158 1.4× 264 2.7× 10 0.2× 18 375
Darika Kingnate Thailand 5 115 0.6× 70 0.4× 125 1.1× 145 1.5× 87 2.0× 7 292
Şebnem Eren Türkiye 10 152 0.9× 63 0.4× 185 1.6× 28 0.3× 44 1.0× 14 374

Countries citing papers authored by Jayantha Liyanage

Since Specialization
Citations

This map shows the geographic impact of Jayantha Liyanage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayantha Liyanage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayantha Liyanage more than expected).

Fields of papers citing papers by Jayantha Liyanage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayantha Liyanage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayantha Liyanage. The network helps show where Jayantha Liyanage may publish in the future.

Co-authorship network of co-authors of Jayantha Liyanage

This figure shows the co-authorship network connecting the top 25 collaborators of Jayantha Liyanage. A scholar is included among the top collaborators of Jayantha Liyanage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayantha Liyanage. Jayantha Liyanage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Steffen, Christoph A., Nathalie El Omeiri, Batmunkh Nyambat, et al.. (2021). Evidence-informed vaccination decision-making in countries: Progress, challenges and opportunities. Vaccine. 39(15). 2146–2152. 21 indexed citations
2.
Vannice, Kirsten, Susan L. Hills, Lauren M. Schwartz, et al.. (2021). The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control. npj Vaccines. 6(1). 82–82. 55 indexed citations
3.
Bahl, Sunil, et al.. (2021). Impact of the COVID-19 pandemic on immunization and surveillance of vaccine-preventable diseases in the WHO South-East Asia Region. WHO South-East Asia Journal of Public Health. 10(Suppl 1). S33–S35. 7 indexed citations
4.
Paul, Repon C., Mahmudur Rahman, Eric Wiesen, et al.. (2018). Hepatitis B Surface Antigen Seroprevalence among Prevaccine and Vaccine Era Children in Bangladesh. American Journal of Tropical Medicine and Hygiene. 99(3). 764–771. 10 indexed citations
5.
Heffelfinger, James D., Xi Li, Batmunkh Nyambat, et al.. (2017). Japanese Encephalitis Surveillance and Immunization — Asia and Western Pacific Regions, 2016. MMWR Morbidity and Mortality Weekly Report. 66(22). 579–583. 100 indexed citations
6.
Sazzad, Hossain M. S., Jeanette J. Rainey, Anna-Léa Kahn, et al.. (2014). Screening for Long-term Poliovirus Excretion Among Children With Primary Immunodeficiency Disorders: Preparation for the Polio Posteradication Era in Bangladesh. The Journal of Infectious Diseases. 210(suppl 1). S373–S379. 5 indexed citations
7.
O’Connor, Patrick, Jayantha Liyanage, Ondrej Mach, et al.. (2011). South-East Asia Regional Update on Measles Mortality Reduction and Elimination, 2003–2008. The Journal of Infectious Diseases. 204(suppl_1). S396–S402. 7 indexed citations
8.
Shakya, Geeta, Yuddha Dhoj Sapkota, Abhijeet Anand, et al.. (2011). Developing Rubella Vaccination Policy in Nepal—Results From Rubella Surveillance and Seroprevalence and Congenital Rubella Syndrome Studies. The Journal of Infectious Diseases. 204(suppl_1). S433–S438. 10 indexed citations
9.
Wilde, Henry, et al.. (1996). Failure of Postexposure Treatment of Rabies in Children. Clinical Infectious Diseases. 22(2). 228–232. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026